Lung Adenocarcinoma-Induced Leptomeningeal Metastasis Complicated by Lemierre Syndrome: A Case Study and Literature Review

• by Xiaoxia Yang, Jingang Han, Zhi Yu, Jianhua Nian, Jie Chen

• January 14, 2026

ESR Essentials: staging and restaging with FDG-PET/CT in oncology—practice recommendations by the European Society for Hybrid, Molecular and Translational Imaging

• by Ricarda Ebner, Gabriel T. Sheikh, Matthias Brendel, Jens Ricke, Clemens C. Cyran

• October 9, 2024

Temple Lung Center | Enrolling Clinical Trials

The Temple Lung Center conducts one of the most comprehensive lung disease clinical trials programs in the country. Our advancements in basic, translational and clinical research are changing lung disease treatment. By pioneering effective therapies, we bring hope to patients with serious and debilitating lung diseases.

• by

• March 23, 2026

• 5 min

Progressive liver impairment as a predictor of reduced survival in individuals with EGFR-mutated non-small cell lung cancer and liver metastases undergoing treatment with EGFR tyrosine kinase inhibitors

• by Wen Zhang, Xuemei Wu, Xiaorong Sun, Jian Wen, Xiaoli He, Mingzhou Zhang, Guansong Wang, Zhi Xu

• January 23, 2026